[1]
2024. SAFETY AND TOLERABILITY OF ARNI (SACUBITRIL VALSARTAN) IN PATIENTS WITH CHRONIC HEART FAILURE. The Research of Medical Science Review. 2, 3 (Dec. 2024), 1992–1996.